Asparaginase
Published: Jul 2025
Next review: Jul 2028
Asparaginase is an enzyme that causes leukaemia cells to die by depriving them of essential nutrients.
This factsheet provides information on the use of asparaginase in children and young people with cancer. Please read this factsheet carefully alongside any patient information provided by the manufacturer. Keep it somewhere safe so you can read it again.
For most medicines, information is provided by the manufacturer in the medicine package. However, this does not always tell you everything you need to know about the use of this medicine in children and young people. We have written this factsheet to give you some extra information.
You can order free physical copies of this publication by adding it to the cart, or you can download the digital version.
How this resource was made
This factsheet was written by Tasneem Khalid, Senior Oncology Pharmacist, The Christie, Manchester, and reviewed by the Neonatal and Paediatric Pharmacists Group (NPPG) Paediatric Oncology Pharmacists Steering Committee on behalf of the CCLG Information Advisory Group, comprising parents, survivors, and multi-professional experts in the field of children’s cancer.
We want our information resources to be relevant and useful. Tell us what you think by completing this short survey or contact us at publications@cclg.org.uk